Assenagon Asset Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.4M | Buy |
69,305
+12,847
| +23% | +$3.38M | 0.02% | 410 |
|
|
2026
Q1 | $15.1M | Buy |
56,458
+52,871
| +1,474% | +$14.3M | 0.02% | 388 |
|
|
2025
Q4 | $900K | Sell |
3,587
-32,625
| -90% | -$8.66M | ﹤0.01% | 957 |
|
|
2025
Q3 | $10.4M | Sell |
36,212
-83,746
| -70% | -$22.4M | 0.01% | 475 |
|
|
2025
Q2 | $31.5M | Buy |
119,958
+116,100
| +3,009% | +$28.3M | 0.05% | 289 |
|
|
2025
Q1 | $898K | Sell |
3,858
-85
| -2% | -$20.6K | ﹤0.01% | 922 |
|
|
2024
Q4 | $904K | Buy |
3,943
+122
| +3% | +$28K | ﹤0.01% | 1115 |
|
|
2024
Q3 | $854K | Buy |
+3,821
| New | +$840K | ﹤0.01% | 1162 |
|
|
2024
Q2 | – | Sell |
-12,929
| Closed | -$2.82M | – | 1455 |
|
|
2024
Q1 | $2.82M | Buy |
12,929
+842
| +7% | +$185K | 0.01% | 758 |
|
|
2023
Q4 | $2.75M | Sell |
12,087
-1,270
| -10% | -$267K | 0.01% | 816 |
|
|
2023
Q3 | $2.69M | Sell |
13,357
-697
| -5% | -$147K | 0.01% | 751 |
|
|
2023
Q2 | $2.91M | Sell |
14,054
-751
| -5% | -$146K | 0.01% | 633 |
|
|
2023
Q1 | $2.92M | Sell |
14,805
-64,384
| -81% | -$13.2M | 0.01% | 716 |
|
|
2022
Q4 | $16M | Buy |
79,189
+27,638
| +54% | +$5.4M | 0.06% | 287 |
|
|
2022
Q3 | $9.07M | Buy |
51,551
+42,016
| +441% | +$8.6M | 0.03% | 362 |
|
|
2022
Q2 | $1.92M | Sell |
9,535
-193,528
| -95% | -$41.3M | 0.01% | 849 |
|
|
2022
Q1 | $46M | Buy |
203,063
+99,876
| +97% | +$23.5M | 0.13% | 136 |
|
|
2021
Q4 | $27.9M | Sell |
103,187
-435,369
| -81% | -$108M | 0.08% | 173 |
|
|
2021
Q3 | $130M | Buy |
538,556
+46,079
| +9% | +$11.6M | 0.42% | 46 |
|
|
2021
Q2 | $117M | Buy |
492,477
+311,168
| +172% | +$70.9M | 0.4% | 47 |
|
|
2021
Q1 | $39.7M | Sell |
181,309
-401,209
| -69% | -$80.5M | 0.16% | 116 |
|
|
2020
Q4 | $102M | Buy |
+582,518
| New | +$101M | 0.44% | 49 |
|
|
2020
Q3 | – | Sell |
-8,757
| Closed | -$1.25M | – | 1250 |
|
|
2020
Q2 | $1.25M | Sell |
8,757
-104,067
| -92% | -$14.4M | 0.01% | 736 |
|
|
2020
Q1 | $12.3M | Sell |
112,824
-39,178
| -26% | -$5.64M | 0.1% | 151 |
|
|
2019
Q4 | $22.1M | Buy |
152,002
+147,241
| +3,093% | +$21.3M | 0.14% | 112 |
|
|
2019
Q3 | $687K | Sell |
4,761
-32,431
| -87% | -$4.73M | ﹤0.01% | 643 |
|
|
2019
Q2 | $5.53M | Sell |
37,192
-52,662
| -59% | -$7.35M | 0.04% | 265 |
|
|
2019
Q1 | $11.8M | Buy |
89,854
+14,626
| +19% | +$1.8M | 0.11% | 168 |
|
|
2018
Q4 | $8.17M | Buy |
75,228
+30,536
| +68% | +$4.09M | 0.09% | 175 |
|
|
2018
Q3 | $6.67M | Buy |
44,692
+33,995
| +318% | +$5.17M | 0.07% | 250 |
|
|
2018
Q2 | $1.65M | Buy |
10,697
+4,437
| +71% | +$670K | 0.02% | 356 |
|
|
2018
Q1 | $870K | Buy |
6,260
+2,262
| +57% | +$332K | 0.01% | 420 |
|
|
2017
Q4 | $548K | Sell |
3,998
-62,959
| -94% | -$8.32M | 0.01% | 599 |
|
|
2017
Q3 | $8.68M | Buy |
+66,957
| New | +$8.93M | 0.08% | 193 |
|
Other funds holding LH
Assenagon Asset Management's LH Position: Q2 2026 in Review
Assenagon Asset Management increased its Labcorp (LH) stake by 23% in Q2 2026, buying an estimated $3.38M and bringing the position to 69,305 shares worth $19.4M. The position accounts for 0.02% of the portfolio, ranked #410.
Assenagon Asset Management first reported a position in LH in Q3 2017 and has held it in 34 quarters since. The position peaked at $130M in Q3 2021. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Assenagon Asset Management held 69,305 shares of Labcorp worth $19.4M as of Q2 2026.
- Assenagon Asset Management bought 12,847 Labcorp shares in Q2 2026, an estimated $3.38M.
- Labcorp made up 0.02% of Assenagon Asset Management's portfolio in Q2 2026, its #410 holding.
- Assenagon Asset Management first reported a position in Labcorp in Q3 2017 and has held it in 34 quarters since.
- Assenagon Asset Management's Labcorp position peaked at $130M in Q3 2021.
- 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.